Los Angeles Biomedical is categorized under Research Services in Torrance, CA and active since 1996.
Los Angeles Biomedical was established in 1996, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research Services business, which does work in the B2B market, and is classified as a Research Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ashley Lee, Administrator at the company’s single location by writing to 1124 West Carson St, Torrance, California CA 90502 or by phoning (310) 222-3604. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Los Angeles Biomedical |
| Contact Person: | Ashley Lee, Administrator |
| Address: | 1124 West Carson St, Torrance, California 90502 |
| Phone Number: | (310) 222-3604 |
| Website Address: | labiomed.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research Services |
| SIC Code: | 8732 |
| NAICS Code: | 6211110 |
| Share This Business: |
Los Angeles Biomedical was started in 1996 to provide professional Research Services under the SIC code 8732 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ashley Lee, Administrator for inquiries that concern Los Angeles Biomedical by calling the company number (310) 222-3604, as your correspondence is most welcome. Additionally, the physical location of the single location of Los Angeles Biomedical can be found at the coordinates 33.83153,-118.29577 as well as the street address 1124 West Carson St in Torrance, California 90502.
For its online presence, you may visit Los Angeles Biomedical’s website at labiomed.com and engage with its social media outlets through on Twitter and on Facebook.